Many expensive cancer drugs have unclear patient benefit
New cancer drugs are being launched at a rapid pace, before their long-term effectiveness for patients can be evaluated. Several years later, most of them still lack scientific evidence for…
My Personal Biomedical Research Feed – Ralph Turchiano, CEO Alchepharma
New cancer drugs are being launched at a rapid pace, before their long-term effectiveness for patients can be evaluated. Several years later, most of them still lack scientific evidence for…
You must be logged in to post a comment.